THE NEW BIOPROCESSING PLATFORM FOR CELL AND GENE THERAPY

MicrofluidX is tackling the problems of process control, scalability, and cost associated with cell bioprocessing, in particular for autologous cell and gene therapy. Its automated, closed technology allows biologists to easily carry out process development by running dozens of cell culture conditions in parallel with extreme process control, and to scale up seamlessly up to several billion cells for manufacturing at a fraction of the current costs. 
 

OUR PARTNERS

©2019 by MicrofluidX